is glp 1 gip the same as tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Understand GLP-1/GIP Dual Agonist Tirzepatide

They are injected directly into a muscle thats surrounded by fat that sits just under the skin

Some patients may notice early changes in sleep quality, recovery, or overall wellness awareness, depending on the protocol

doi:10.1016/j.diabres.2015.12.022 92

Individual responses vary, but most people need to stay consistent for at least 4 to 8 weeks to notice significant changes in energy, skin health, or overall well-being

DOI: 10.1002/oby.23725 Other authors of the study include Junzheng Wang, Medical Sciences Office, Oxford University, Clinical Academic Graduate School, University of Oxford, Oxford, United Kingdom and Francois Venter, Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa